|Day Low/High||67.85 / 68.98|
|52 Wk Low/High||42.08 / 75.93|
Investors in Teladoc Inc saw new options become available this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TDOC options chain for the new December 15th contracts and identified one put and one call contract of particular interest.
Bringing new paradigm in healthcare delivery to life with integration of Teladoc and Best Doctors services
Investors in Teladoc Inc saw new options begin trading this week, for the November 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TDOC options chain for the new November 17th contracts and identified one put and one call contract of particular interest.
Validates Teladoc's commitment to protecting sensitive protected healthcare information
Acquisition paves the way for Teladoc to deliver on new paradigm for healthcare delivery
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABT, BH, CUBN, PYPL, REIS Downgrades: FRED, FSBC, TDOC Initiations: BBU, CLSD Read on to get TheStreet Quant Ratings' detailed report:
Wednesday's session saw strength in small-caps as well as transports.
Acquisition gives Teladoc an international footprint and significantly expands breadth of healthcare solutions
In recent trading, shares of Teladoc Inc have crossed above the average analyst 12-month target price of $30.85, changing hands for $32.60/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Teladoc Inc . The average 12-month price target for TDOC — averaging the work of 13 analysts — reveals an average price target of $29.31/share.
Teladoc Readiness Assessment¿ Tool Used to Set Course for Telehealth Rollout
Jim Cramer takes a closer look at Sirius XM Radio, Shopify, Teledoc, Sarepta Therapeutics, Pilgrim's Pride.
It's not about fashion missteps, says Jim Cramer. Who cares what the products look like if there's no one in the stores?
New telemedicine bill paves the way for pro-telemedicine legislation nationwide
In recent trading, shares of Teladoc Inc have crossed above the average analyst 12-month target price of $27.18, changing hands for $28.60/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.